Dual Frequency Low-Level Laser Therapy in Myofascial Trigger Points of Upper Trapezius

NCT ID: NCT07137728

Last Updated: 2025-09-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-08-25

Study Completion Date

2026-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to learn if dual frequency low-level laser therapy (DF-LLLT) works to reduce pain and improve neck function in adults with myofascial trigger points in the upper trapezius muscle. It will also determine whether DF-LLLT improves cervical range of motion.

The main questions it aims to answer are:

i)Does DF-LLLT reduce pain intensity on the Visual Analog Scale (VAS) more than sham laser therapy? ii)Does DF-LLLT improve functional status (Neck Disability Index) and cervical range of motion more than sham laser therapy?

Researchers will compare DF-LLLT plus conventional therapy to sham laser plus conventional therapy to see if DF-LLLT has greater therapeutic effects.

Participants will:

1. Receive either DF-LLLT or sham laser therapy twice weekly for 4 weeks
2. Perform a standardized stretching and strengthening exercise program for the neck and shoulders.
3. Attend clinic visits at baseline, week 2, and week 4 for assessments of pain, function, and cervical mobility.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Myofascial trigger points (MTrPs) in the upper trapezius muscle are a frequent source of neck pain, muscle stiffness, and reduced cervical mobility. They are characterized by hypersensitive palpable nodules within taut muscle fibers that can produce local and referred pain. Traditional management strategies include stretching, strengthening, and various physical therapy modalities, but recurrence and incomplete relief are common.

Low-level laser therapy (LLLT) is a non-invasive photobiomodulation technique shown to reduce pain and inflammation and promote tissue healing. Dual frequency LLLT may provide enhanced therapeutic effects compared to single frequency LLLT by delivering both continuous and pulsed light energy to targeted tissues. However, clinical evidence for its use in upper trapezius MTrPs is limited.

This single-blinded randomized controlled trial will recruit 32 male and female participants aged 20-55 years who meet the diagnostic criteria for MTrPs according to Simons' guidelines. Participants will be randomly assigned to one of two groups:

Experimental group: DF-LLLT (830 nm, 100 mW/cm², 9.12 Hz, 5 J/cm²) applied perpendicularly over each identified MTrP for 3 minutes 9 seconds per point, twice weekly for 4 weeks, plus a standardized stretching and strengthening program.

Control group: Sham laser therapy with identical appearance and application time but without light emission, plus the same exercise program.

Primary and secondary outcomes will be assessed at baseline, week 2, and week 4:

Primary outcome: Change in pain intensity measured using the Visual Analog Scale (VAS)

Secondary outcomes: Change in functional status (Neck Disability Index) and change in cervical range of motion (flexion, extension, lateral flexion, and rotation) measured with a goniometer.

The study aims to determine whether DF-LLLT provides superior pain relief, functional improvement, and mobility gains compared to sham laser therapy when combined with conventional exercises. Statistical analysis will be performed using SPSS 21.0, with significance set at p ≤ 0.05.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myofascial Pain Syndrome (MPS) Upper Trapezius Muscle Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants will be randomly assigned into two groups:

1. Experimental group:

Dual frequency low-level laser therapy plus conventional therapy.
2. Control group:

Sham laser therapy plus conventional therapy.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
The outcomes assessor will be blinded to group allocation. The sham laser device will look and sound identical to the active device but will not emit therapeutic light, ensuring participants are unaware of their group assignment.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dual Frequency Low-Level Laser Therapy + Conventional Therapy

Participants will receive dual frequency low-level laser therapy (DF-LLLT) at 830 nm, 100 mW/cm², 9.12 Hz, 5 J/cm², applied perpendicularly over each identified myofascial trigger point in the upper trapezius muscle for 3 minutes 9 seconds per point, twice weekly for 4 weeks. In addition, they will perform a standardized stretching and strengthening exercise program for the neck and shoulders.

Group Type EXPERIMENTAL

Dual Frequency Low-Level Laser Therapy

Intervention Type DEVICE

DF-LLLT (830 nm, 100 mW/cm², 9.12 Hz, 5 J/cm²) applied over each identified trigger point for 3 minutes 9 seconds per point, twice weekly for 4 weeks.

Conventional Therapy (Stretching and Strengthening Program)

Intervention Type OTHER

A standardized physiotherapy program including stretching and strengthening exercises for the cervical and shoulder muscles. The program is performed under physiotherapist supervision twice weekly for 4 weeks. Exercises are identical across both study arms and include stretching of the upper trapezius and strengthening of the neck and scapular stabilizer muscles.

Sham Laser + Conventional Therapy

Participants will receive sham laser therapy with identical appearance, sounds, and application time as the experimental laser but without light emission. In addition, they will perform the same standardized stretching and strengthening exercise program for the neck and shoulders.

Group Type PLACEBO_COMPARATOR

Sham Laser

Intervention Type DEVICE

Inactive laser device identical in appearance and sound to the active laser but without light emission, applied for 3 minutes 9 seconds per point, twice weekly for 4 weeks.

Conventional Therapy (Stretching and Strengthening Program)

Intervention Type OTHER

A standardized physiotherapy program including stretching and strengthening exercises for the cervical and shoulder muscles. The program is performed under physiotherapist supervision twice weekly for 4 weeks. Exercises are identical across both study arms and include stretching of the upper trapezius and strengthening of the neck and scapular stabilizer muscles.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dual Frequency Low-Level Laser Therapy

DF-LLLT (830 nm, 100 mW/cm², 9.12 Hz, 5 J/cm²) applied over each identified trigger point for 3 minutes 9 seconds per point, twice weekly for 4 weeks.

Intervention Type DEVICE

Sham Laser

Inactive laser device identical in appearance and sound to the active laser but without light emission, applied for 3 minutes 9 seconds per point, twice weekly for 4 weeks.

Intervention Type DEVICE

Conventional Therapy (Stretching and Strengthening Program)

A standardized physiotherapy program including stretching and strengthening exercises for the cervical and shoulder muscles. The program is performed under physiotherapist supervision twice weekly for 4 weeks. Exercises are identical across both study arms and include stretching of the upper trapezius and strengthening of the neck and scapular stabilizer muscles.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women aged 20-55 years.
* Diagnosis of myofascial pain based on Simons criteria.
* At least two trigger points in the upper trapezius muscle.
* Pain duration ≥ 3 months.
* VAS pain score ≥ 5.
* Limited cervical range of motion due to trigger points.

Exclusion Criteria

* Pregnancy.
* Use of anticoagulants.
* Bleeding disorders or dermatological diseases at treatment site.
* History of infectious, inflammatory, tumoral, cardiopulmonary, psychiatric, or systemic diseases.
* Kellgren stage 3-4 cervical osteoarthritis or cervical disc herniation causing radiculopathy.
* Diagnosis of fibromyalgia.
* Inability to follow instructions or complete questionnaires.
Minimum Eligible Age

20 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Lahore

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UOL/IREB/25/09/0006

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.